QIAGEN QIAstat-Dx syndromic testing instrument

Monday, 01 April, 2019 | Supplied by: QIAGEN Pty Ltd



In the near-patient clinical lab, acute conditions like respiratory disease require immediate intervention. Correct identification of the causative pathogen is key to selecting the right treatment, but many respiratory pathogens cause similar symptoms. This makes it difficult for scientists to know which one they’re up against.

Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving users the answers they need when they need them.

Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time. The TGA registered panels are available now in Australia.

For more information: https://qiastat-dx.com/row/are-you-ready-for-a-new-era-in-multiplex-syndromic-testing/.

Online: www.qiagen.com
Phone: 03 9840 9800
Related Products

DMT Starter System tissue organ bath system for education

The sleek Starter System by DMT is a tissue organ bath that teaches students about the variation...

PCR Biosystems RiboShield RNase Inhibitor

PCR Biosystems' RiboShield RNase Inhibitor is now available as a standalone product. The...

Cayman Chemical Testosterone ELISA Kit

Cayman Chemical's Testosterone ELISA Kit is a competitive assay that can be used for the...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd